At a Glance
| 1cP-AL-LAD | 1cP-LSD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 100–225 µg | 75–150 µg |
| Total Duration | 3.3–7 hrs | 4.1–8 hrs |
| Routes | oral | oral |
| Effects | 72 documented | 77 documented |
Dosage
oral
| Level | 1cP-AL-LAD | 1cP-LSD |
|---|---|---|
| Threshold | 20 µg | 15 µg |
| Light | 50–100 µg | 25–75 µg |
| Common | 100–225 µg | 75–150 µg |
| Strong | 225–350 µg | 150–300 µg |
| Heavy | 350 µg | 300 µg |
Duration
oral
1cP-AL-LAD
oral
Total: 7 hrs – 10 hrsPeak
Offset
Afterglow
Onset20 min – 1 hrs
Come Up30 min – 1 hrs
Peak2.5 hrs – 5 hrs
Effects
Safety
Interaction: 1cP-AL-LAD + 1cP-LSD
No direct interaction data available between these substances. This does not mean the combination is safe.
1cP-AL-LAD — Dangerous Interactions
No dangerous interactions recorded.
1cP-LSD — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between 1cP-AL-LAD and 1cP-LSD?
1cP-AL-LAD is classified as a Psychedelic (Lysergamides) while 1cP-LSD is classified as a Psychedelic (Lysergamides). They share 63 effects in common, with 9 effects unique to 1cP-AL-LAD and 14 unique to 1cP-LSD.
Is it safe to combine 1cP-AL-LAD and 1cP-LSD?
There is no direct interaction data available for combining 1cP-AL-LAD and 1cP-LSD. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, 1cP-AL-LAD or 1cP-LSD?
At common doses via oral, 1cP-AL-LAD is typically dosed at 100–225 µg while 1cP-LSD is dosed at 75–150 µg. However, "stronger" depends on context — potency, subjective intensity, and duration all factor in. These substances have different pharmacological profiles and comparing raw potency is not straightforward.